Drug & medication recalls Moderate risk

Betaxolol Ophthalmic Solution recalled over manufacturing violations

Recall date
October 13, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Akorn, Inc. recalls Betaxolol Ophthalmic Solution, USP 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL per bottle, Sterile, Rx Only, Manufactured by:…
Recall number
D-0135-2023
FDA classification
Class II
Brand / firm
Akorn, Inc.
Sold / distributed
Nationwide in the USA

Why it was recalled

CGMP Deviations:

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Betaxolol Ophthalmic Solution, USP 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-705-10

Get recall alerts

Free email alert whenever Akorn, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Akorn, Inc.